Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04341740 · ClinicalTrials.gov registry record · NA
Investigating Marrow Infiltrating Lymphocytes in Renal Cell Carcinoma
A NA study, sponsored by University of Oklahoma.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04341740: Clinical Trial NA study, sponsored by University of Oklahoma.
NCT04341740 is a NA study that was terminated before completion, run by University of Oklahoma. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04341740, a NA study, was terminated before completion, sponsored by University of Oklahoma.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this research is to collect health-related information as well as bone marrow and blood specimens to determine if a new form of treatment for patients with kidney and bladder cancer may be possible.
Primary Outcome
A successful expansion will be greater than or equal to 50% viable and greater than or equal to 50% CD3 positive.
Interventions
- PROCEDURE Bone Marrow Aspirate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-07-22 |
| Est. Completion | 2021-04-09 |
| Phase | NA |
Why NCT04341740 stopped before completion
NCT04341740 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Bone Marrow Aspirate is the first listed.
NCT04341740 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04341740 about?
NCT04341740 is a clinical study titled "Investigating Marrow Infiltrating Lymphocytes in Renal Cell Carcinoma". The purpose of this research is to collect health-related information as well as bone marrow and blood specimens to determine if a new form of treatment for patients with kidney and bladder cancer may be possible.
What is the current status of trial NCT04341740?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2020-07-22. Estimated completion is 2021-04-09.
What interventions are being tested in trial NCT04341740?
The interventions under investigation include: Bone Marrow Aspirate (PROCEDURE).
Who is sponsoring clinical trial NCT04341740?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04341740's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI